Vascular Grafts Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Vascular Grafts Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Vascular Grafts Market Research
Report The latest report by IMARC, titled
Vascular Grafts Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 " the global vascular grafts market
reached a value of US 1.8 Billion in 2022.
Vascular grafts are medical devices used to
replace or repair damaged blood vessels. They are
made from synthetic materials or harvested from a
patient's tissue, such as veins or arteries. They
are used in various surgical procedures,
including coronary artery bypass surgery,
peripheral artery bypass surgery, and
hemodialysis access. Several types of vascular
grafts are available, including synthetic,
biological, and hybrid grafts. Synthetic grafts,
such as polytetrafluoroethylene (PTFE) and
expanded polytetrafluoroethylene (ePTFE), are
commonly used due to their durability and
resistance to infection. Biological grafts, such
as bovine or porcine-derived grafts, are also
available that offer a more natural structure
better suited to certain procedures. Hybrid
grafts, which combine synthetic and biological
materials, are sometimes used. Vascular grafts
restore blood flow to damaged or diseased blood
vessels. They can be used to bypass blockages or
narrowings in arteries to provide access for
hemodialysis or to repair damaged vessels caused
by trauma or disease. The success of a vascular
graft procedure depends on several factors,
including the graft type used, the size and
location of the damaged vessel, and the patient's
overall health. Vascular grafts can be customized
to fit the patient's specific needs, with options
like synthetic or biological materials, different
sizes and shapes, and the ability to combine
materials for hybrid grafts. Request Free Sample
Report https//www.imarcgroup.com/vascular-grafts
-market/requestsample
4
Report Description and Highlights
Report Description

Global Vascular Grafts Market Trends The global
market is primarily driven by the growing
prevalence of peripheral arterial disease,
aneurysms, and end-stage renal disease. As the
population ages and lifestyles become more
sedentary, the incidences of these conditions
increases, leading to a greater need for vascular
grafts to restore blood flow and prevent serious
health complications. In line with this,
continuous technological advances are
significantly contributing to the market growth.
Furthermore, rising healthcare expenditures are
positively influencing the market. Apart from
this, the development of advanced medical
devices, such as imaging technologies, artificial
intelligence, and robotics, is catalyzing the
product demand. Moreover, the escalating
awareness of the benefits offered by vascular
grafts among patients, physicians, and other
healthcare professionals is propelling the
market. Besides, the rising number of dialysis
procedures and the escalating chronic kidney
disease (CKD) cases globally are favoring the
market. The widespread availability of
reimbursement policies is strengthening the
market worldwide. Additionally, extensive
utilization of prosthetic grafts, such as
electrospun polyurethane vascular grafts for
complex vascular trauma as it lowers the risks of
neointimal formation, is expected to provide a
boost to the market. On account of the factors
above, the market is anticipated to reach a value
of US 2.6 Billion by 2028, exhibiting a CAGR of
6.1 during 2023-2028. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product En
dovascular Stent Grafts Hemodialysis Acc
ess Grafts Coronary Artery By-Pass Graft
s Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts
Breakup by Raw Material
Polytetrafluoroethylene (PTFE) Polyester
Polyurethane
Biosynthetic Breakup by Application Ca
rdiac Aneurysm Kidney Failure
Vascular Occlusion

6
Report Description and Highlights
Report Description
Coronary Artery Disease
Breakup by End User Hospitals
Ambulatory Surgical Centers (ASCs)
Breakup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Austra
lia Indonesia
Others Europe Germany

7
Report Description and Highlights
Report Description
France United
Kingdom Italy
Spain Russia O
thers Latin America Br
azil Mexico Ot
hers Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH Co. KG)
  Becton Dickinson and Company Cook Group Incorporat
  ed Cordis CryoLife Inc. Getinge AB Heat Medical Eu
  rope BV LeMaitre Vascular Medtronic plc Terumo Cor
  poration W. L. Gore Associates Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/vascular-grafts-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us